Neopterin in patients with early rheumatoid arthritis
https://doi.org/10.14412/1995-4484-2008-851
Abstract
62 pts with early rheumatoid arthritis (RA) were included. Neopterin changes dependence on RA clinical course and duration, acute phase markers (ESR, CRP) changes, presence of IgG and IgM rheumatoid factors, autoantibodies against cyclic citrullinated peptide as well as neopterin prognostic significance were evaluated. Immuno-inflammatory process presentation in RA was most often accompanied by elevation of neopterin serum concentration associated with more severe clinical course of early RA, significant antibody formation and radiological progression. These data can prove prognostic significance and utility of neopterin evaluation in early RA.
References
1. <div><p>Клинические рекомендации. Ревматология. Под ред. Е.Л. Насонова. — М.: ГЕОТАР-Медиа, 2005, 25- 71.</p><p>Насонов Е.Л., Самсонов М.Ю, Чичасова Н.В., др. Неоптерин: лабораторный маркер активации клеточного иммунитета при ревматоидном артрите. Тер. архив, 1998, 5, 28 — 31.</p><p>Насонов Е.Л., Самсонов М.Ю, Т.П. Тилз (G.P. Tilz), Д.Фукс (D. Fuchs) Неоптерин: новый иммунологический маркер аутоиммунных ревматических заболеваний. Клинич. мед., 2000, № 8, 43 — 46.</p><p>Никифорова Е.Л. Клиническое и прогностическое значение С-реактивного белка и неоптерина при ревматоидном артрите. Автореф. дис...... Клинич. мед., М., 1999, 25.</p><p>Степанец О.В., Насонова М.Б., Чичасова Н.В., Насонов Е.Л. Растворимые рецепторы фактора некроза опухоли А 55 KDA (РФНО - 55Р) при ревматоидном артрите, взаимосвязь с другими маркерами иммунологической активации (РИЛ-2РА, ИЛ-13, неоптерином). Науч.-практич. ревматология. Тезисы Конгресса ревматологов России,2003 г., Саратов. Приложение № 2, 2003, 95.</p><p>Becham J.C., Caldwell D.C., Peterson B.F. et al. Disease severity in rheumatoid arthritis: relashionships of plasma tumor necrosis factor-alfa, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin and fibrin D-dimer to traditional severity and functional measures. J. Clin. Immunol., 1992, 12, 353 — 361.</p><p>Egg D., Gunther R., Fuchs D. et al. Neopterin as indicator for activation of cellular immunity in rheumatoid arthritis. Bioch. Clin. Asp. Of Pteridines, 1984, 3, 491 -502.</p><p>Emery P., Breedveld F.C., Dougados M. et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical quide. Ann. Rheum. Dis., 2002, 61 (4), 290 — 297.</p><p>Feldman М., Brennar F.M., Maini R.N. Rheumatoid arthritis. Cell., 1996, 85, 307 - 310.</p><p>Feldman М., Brennar F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Ann. Rev. Rheumatol. Dis., 1996, 14, 397-440.</p><p>Hannonen P., Fikanoja S., Nacola M. et al. Urinary neopterin index as measuer of rheumatoid activity. Scand. J. Rheumatol., 1986, 15, 2, 148— 152.</p><p>Horneff G., Sack U., Kalden J.R. et al. Reduction of monocytes-macrofage activation marker upon anti CD4 treatment. Decreased levels ofIL-1, IL-6, neopterin and soluble CD 14 in patients with rheumatoid arthritis. Clin. Exp. Immunol., 1993, 91, 2, 207 — 213.</p><p>Krause A., Prots H., Goebel M. Correlation between synovial neopterin and inflammatory activity in rheumatoid arthritis. Ann. Rheumat. Dis., 1989, 48, 636 - 640.</p><p>Kroot E.J., de Jong B.A., van Leeuwen M.A. et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patient with recent-onset rheumatoid arthritis. Arthr. Rheuma. Dis., 2000, 43 (8), 1831 — 1835.</p><p>Nathan C. Perodid and pteridine: A Hypothesis of the regulation of macrophage antimicrobial activity by inteiferon-gamma. Interferon. Ed.J.Gresser. London. Acad.Press., 1986, 125 — 143.</p><p>Smolen J.S. Antibodies in rheumatoid arthritis. Autoantibody Manual с1.1, 1996, 1, 1.</p><p>Wascher H., Fuchs D., Hausen A et al. Neopterin as marker for activation of cellular immuniti: immunological basis and clinical application. Advanc. Clin. Chem., 1989, 27, 81 - 141.</p></div><br />
Review
For citations:
Lysak N.V., Bugrova O.V. Neopterin in patients with early rheumatoid arthritis. Rheumatology Science and Practice. 2008;46(1):31-35. (In Russ.) https://doi.org/10.14412/1995-4484-2008-851
Views:
847
Email this article 